TRYPTO Therapeutics

Trypto therapeutics email format

Verified email-pattern data for Trypto Therapeutics is currently limited. You can still use the company insights and contact sections below.
TRYPTO Therapeutics develops a novel class of Tryptophan Hydroxylase inhibitors for serotonin-dependent diseases. The overproduction of peripheral serotonin, catalyzed by the enzyme Tryptophan Hydroxylase 1, leads to the aggravation of many chronic and life-threatening diseases, such as Pulmonary Arterial Hypertension (PAH), Carcinoid Syndrome (CS), colorectal cancer (CRC) and obesity. We have developed and patented a novel class of TPH inhibitors (TPHi) with nanomolar potency in vitro to reduce the pathologically high serotonin synthesis in the periphery. Our new generation of TPHi differs in the scaffold, binding mode, and potency from the two TPHi currently on the market or under clinical investigation.
Looking for a particular TRYPTO Therapeutics employee's phone or email?

Trypto Therapeutics Questions

Top TRYPTO Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant